Physician
Pathology
Dr. Win Naing, MD
|
|
Give Review
Dr. Win Naing works in the field of Pathology. Win Naing is a published doctor as well. He has 11 publications published. The latest was: Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase.
Publications
- Distribution of common genetic subgroups in childhood acute lymphoblastic leukemia in four developing countries.
- Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase.
- Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase.
- Positron emission tomography and carcinosarcoma of the esophagus.
- Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist.
- Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase.
- Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.
- SD0006: a potent, selective and orally available inhibitor of p38 kinase.
- Left extended hepatectomy for a metastatic gastrointestinal stromal tumor after a disease-free interval of 17 years: report of a case.
- Immunohistochemical expression of the transcription factor DP-1 and its heterodimeric partner E2F-1 in non-Hodgkin lymphoma.
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Southern California - LAC+USC Medical Center -
University Institute of Medicine 1
Drug Facts
| NPI NUMBER | 1972615771 | |
| NPPES Provider LastName | NAING | |
| NPPES Provider FirstName | WIN | |
| NPPES Provider ZIPCode | 917312629 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 515.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1972615771 |
| Last Name Of The Provider | NAING |
| First Name Of The Provider | WIN |
| View All |